ADAMTS-13 levels do not predict outcome in thrombotic thrombocytopenic purpura: Protein S levels are maintained during plasma exchange with solvent detergent treated plasma

被引：0
|
作者：
Rock, Gail A. [1 ]
Anderson, David [2 ]
Benny, Barrett [3 ]
Barth, David [4 ]
Clark, William [5 ]
Foley, Ronan [6 ]
Sutton, David [4 ]
Leblond, Pierre [7 ]
机构：
[1] Canadian Apheresis Grp, Ottawa, ON, Canada
[2] Queen Elizabeth II HSC, Halifax, NS, Canada
[3] Vancouver Gen Hosp, Vancouver, BC, Canada
[4] Princess Margaret Hosp, Toronto, ON, Canada
[5] Hlth Sci Ctr, London, England
[6] Henderson Gen Hosp, Hamilton, ON, Canada
[7] Hop Enfants Jesus, Quebec City, PQ, Canada
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2895.2895
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2895
引用
收藏
页码：852A / 852A
页数：1
相关论文
共 50 条
  • [21] ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences
    Feys, HB
    Liu, F
    Dong, N
    Pareyn, I
    Vauterin, S
    Vandeputte, N
    Noppe, W
    Ruan, C
    Deckmyn, H
    Vanhoorelbeke, K
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) : 955 - 962
  • [22] Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura
    Gangemi, Sebastiano
    Allegra, Alessandro
    Sciarrone, Paolo
    Russo, Sabina
    Cristani, Mariateresa
    Gerace, Demetrio
    Saitta, Salvatore
    Alonci, Andrea
    Musolino, Caterina
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (04) : 368 - 373
  • [23] STUDY OF ADAMTS13 LEVELS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) DURING PREGNANCY
    Piras, F.
    Russo, L.
    Marchetti, M.
    Barcella, L.
    Testa, M.
    Rambaldi, A.
    Noris, M.
    Savignano, C.
    Toschi, V.
    Falanga, A.
    HAEMATOLOGICA, 2015, 100 : 571 - 571
  • [24] Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura
    Sui, Jingrui
    Cao, Wenjing
    Halkidis, Konstantine
    Abdelgawwad, Mohammad S.
    Kocher, Nicole K.
    Guillory, Bryan
    Williams, Lance A.
    Gangaraju, Radhika
    Marques, Marisa B.
    Zheng, X. Long
    BLOOD ADVANCES, 2019, 3 (24) : 4177 - 4186
  • [25] Discrepant activity levels of von Willebrand factor-cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura
    Studt, JD
    Hovinga, JAK
    Furlan, M
    Lämmle, B
    BLOOD, 2003, 102 (03) : 1148 - 1148
  • [26] Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
    Zheng, XL
    Kaufman, RM
    Goodnough, LT
    Sadler, JE
    BLOOD, 2004, 103 (11) : 4043 - 4049
  • [27] Longitudinal Assessment of Plasma ADAMTS13 Biomarkers Helps Predict Recurrence of Immune Thrombotic Thrombocytopenic Purpura
    Sui, Jingrui
    Cao, Wenjing
    Abdelgawwad, Mohammad S.
    Halkidis, Konstantine
    Kocher, Nicole K.
    Guillory, Bryan K.
    Williams, Lance A., III
    Marques, Marisa B.
    Gangaraju, Radhika
    Zheng, X. Long
    BLOOD, 2019, 134
  • [28] Plasma therapy in thrombotic thrombocytopenic purpura:: Review of the literature and the bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency
    Fontana, S
    Hovinga, JAK
    Studt, JD
    Alberio, L
    Lämmle, B
    Taleghani, BM
    SEMINARS IN HEMATOLOGY, 2004, 41 (01) : 48 - 59
  • [29] Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study
    Schieppati, Francesca
    Russo, Laura
    Marchetti, Marina
    Barcella, Luca
    Cefis, Maurizio
    Rosas, Patricia G.
    Caldara, Gloria
    Carpenedo, Monica
    D'Adda, Mariella
    Rambaldi, Alessandro
    Savignano, Chiara
    Billio, Atto
    Franco, Massimiliano Bruno
    Toschi, Vincenzo
    Falanga, Anna
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) : 953 - 959
  • [30] Solvent/detergent treated plasma, Octaplas and universally applicable plasma, in TTP and HUS:: Quantification of ADAMTS13 and factor H levels
    Heger, A.
    Kannicht, C.
    Römisch, J.
    Svae, T. E.
    VOX SANGUINIS, 2006, 91 : 173 - 173
12345